Research Application Process
Lakeridge Health Research Application Process
The approval process at Lakeridge Health (LH) is two pronged - REB and Administrative.
Research Ethics Review
A submission to the Lakeridge Health REB will consist of completion of the Lakeridge Health Research Ethics Board Application Form. A Lakeridge Health Site Principal Investigator is required for all studies. All applicable areas of the application form must be signed before submission. Incomplete applications will not be processed and will be returned to the Principal Investigator. Please allow sufficient time for review of the application and protocol when requesting program approval.
Electronic submission of the REB package may include:
- Lakeridge Health Research Ethics Board Application (mandatory)
- Full protocol/proposal (mandatory)
- Consent Forms/Information Letters (LH logo in header and version/date in footer)
- Data Collection Forms/Case Report Forms
- Recruitment information (flyer, phone script, wallet cards)
- Investigator Brochure/Product Monograph/ Device Manual
- Health Canada No Objection Letter
- Other REB letters of approval
- Department Impact Forms
- Study Contract/Agreement
- Team Form and all supporting documents
Note: If supporting documents have been previously submitted, contact the Research Liaison to verify they are up-to-date. All research team members are required to complete the TCPS2 Tutorial (as per the research team form).
Once the package is screened for completeness, the study is assigned a research identification number (RID#). All initial approvals are reviewed by the full Board. The PI will be requested to attend Research Ethics Board meeting to provide a brief overview of the study and provide clarification if required.
Administrative Review
Administrative approval requires approval of the department impact, resource utilization (including sufficient funds to cover all expenses related to the study), and execution of a research Contract/Agreement. A Department Impact Form must be completed for all studies conducted at Lakeridge Health, regardless of whether or not the impact is financial in nature. If there isn't an impact to declare, this must be indicated on the form.
All studies require a clinical trial agreement (CTA), data sharing agreement or collaboration agreement. Agreements outline roles and responsibilities, insurance, indemnification, budget etc. Agreements can be forwarded to REB@lh.ca.
Once both approvals are in place, a 'Notification to Commence' is issued with a date of commencement. A study cannot commence until this has been received.
For more information, please read our process for ethics review PDF.
Contact
If you would like more information about the Lakeridge Health REB, or if you have questions, please contact:
Lori-Ann Larmand
Research Liaison/REB Coordinator
Lakeridge Health Oshawa, G-Wing, Level: B1, Room: 118
1 Hospital Court
Oshawa, ON L1G 2B9
Tel: 905-576-8711 ext. 32745
Email: Lori-Ann Larmand, REB@lh.ca.